SERA Prognostics General Counsel Jackson Benjamin sold 2,190 shares at $2 per share on 2026-09-10, leaving him with 159,566 shares. The sale represented about 1.4% of his prior holding, a limited transaction relative to the shares he held before the sale.
Key Highlights
- Jackson Benjamin held 159,566 SERA Prognostics shares after the transaction.
- The sale represented about 1.4% of Benjamin’s prior shares holding.
- The transaction occurred on 10 September 2026 under SEC transaction code S.
SERA PROGNOSTICS, INC. (NASDAQ: SERA) saw its General Counsel Jackson Benjamin sell 2,190 shares at $2 per share. The transaction involved Benjamin’s shares in the company.
Benjamin’s 2,190-Share Sale
Jackson Benjamin serves as General Counsel of SERA PROGNOSTICS, INC. He sold the shares on 10 September 2026 at $2 per share. The transaction was reported under SEC transaction code S. The filing reports a sale of 2,190 shares in SERA PROGNOSTICS, INC. Benjamin’s role as General Counsel was identified in connection with the transaction.
Post-Sale Ownership and Transaction Size
Benjamin owned 159,566 shares after the sale. The transaction represented about 1.4% of his prior shares holding. Transaction code S denotes an open-market or private sale.
FAQs
Q: What did Jackson Benjamin sell in SERA Prognostics?
A: Jackson Benjamin, SERA Prognostics’ General Counsel, sold 2,190 shares at $2 per share on 10 September 2026. The transaction used SEC code S.
Q: How many SERA Prognostics shares does Jackson Benjamin own after the sale?
A: After the reported sale, Jackson Benjamin owned 159,566 SERA Prognostics shares, according to the filing. The transaction involved 2,190 shares.
Q: What percentage of Benjamin’s prior holding did the SERA sale represent?
A: The SERA Prognostics transaction represented about 1.4% of Jackson Benjamin’s prior shares holding. The filing describes the transaction as about 1.4% of that prior holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.